Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-06

Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Rituximab in Combination With Glucocorticoids in Participants With Wegener's Granulomatosis or Microscopic Polyangitis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating safety and efficacy of rituximab combined with glucocorticoids in Wegener's Granulomatosis (granulomatosis with polyangiitis) or micros…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rituximab (rituximab)
  • glucocorticoids (glucocorticoids)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Wegener's Granulomatosis or Microscopic Polyangiitis | Phase 4 | Status: COMPLETED